TECH vs WST · P/E 65, rev $1.22B vs P/E 35, rev $2.89B
Bio-Techne Corp (TECH) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the TECH and WST stock pages for the full models.
Not investment advice.